Deciphering Mechanisms of K-Ras Signaling through B-Raf Kinase

被引：0
|
作者：
Pathirage, Kasun [1 ]
Mattos, Carla [1 ]
机构：
[1] Northeastern Univ, Boston, MA 02115 USA
来源：
PROTEIN SCIENCE | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
ABS160
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A Phase IB study of RAF dimer inhibitor BGB-283 in patients with B-RAF or K-RAS/N-RAS mutated solid tumors
    Desai, Jayesh
    Gan, Hui
    Barrow, Catherine
    Jameson, Michael B.
    Solomon, Ben
    Atkinson, Victoria
    Haydon, Andrew
    Millward, Michael
    Begbie, Stephen
    Brown, Michael
    Markman, Benjamin
    Patterson, William
    Hill, Andrew
    Horvath, Lisa
    Nagrial, Adnan
    Richardson, Gary
    Jackson, Christopher
    Friedlander, Michael
    Gibbs, David
    Parente, Phillip
    Yang, Jason
    Wang, Lai
    Chen, Yunxin
    Luo, Lusong
    CANCER RESEARCH, 2017, 77
  • [22] Selective Regulation of B-Raf Dependent K-Ras/Mitogen-Activated Protein by Natural Occurring Multi-kinase Inhibitors in Cancer Cells
    Abd El Maksoud, Ahmed I.
    Taher, Rehab F.
    Gaara, Ahmed H.
    Abdelrazik, Eman
    Keshk, Omar S.
    Elawdan, Khaled A.
    Morsy, Salwa E.
    Salah, Ahmed
    Khalil, Hany
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [23] K-RAS AND B-RAF MUTATION AND CETUXIMAB THERAPY IN ADVANCED COLORECTAL CANCER PATIENTS : A RETROSPECTIVE MONOISTITUTIONAL STUDY.
    Frisinghelli, M.
    Soini, B.
    Ambrosini, G.
    Caffo, O.
    Caldara, A.
    Girlando, S.
    Barbareschi, M.
    Cuorvo, L., V
    Dalla Palma, P.
    Galligioni, E.
    ANNALS OF ONCOLOGY, 2009, 20
  • [24] c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma
    Blasco, Rafael B.
    Francoz, Sarah
    Santamaria, David
    Canamero, Marta
    Dubus, Pierre
    Charron, Jean
    Baccarini, Manuela
    Barbacid, Mariano
    CANCER CELL, 2011, 19 (05) : 652 - 663
  • [25] Transformation potency of ErbB heterodimer signaling is determined by B-Raf kinase
    M Hatakeyama
    N Yumoto
    X Yu
    M Shirouzu
    S Yokoyama
    A Konagaya
    Oncogene, 2004, 23 : 5023 - 5031
  • [26] The relationship between common EGFR, b-raf, k-ras mutations, and prognosis in advanced-stage NSCLC with response to the treatment
    Dogan, M.
    Demirkazik, A.
    Tukun, A.
    Akbulut, H.
    Sak, S. Dizbay
    Ceyhan, K.
    Yalcin, B.
    Icli, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Transformation potency of ErbB heterodimer signaling is determined by B-Raf kinase
    Hatakeyama, M
    Yumoto, N
    Yu, X
    Shirouzu, M
    Yokoyama, S
    Konagaya, A
    ONCOGENE, 2004, 23 (29) : 5023 - 5031
  • [28] B-Raf and C-Raf signaling investigated in a simplified model of the mitogenic kinase cascade
    Robubi, A
    Mueller, T
    Fueller, J
    Hekman, M
    Rapp, UR
    Dandelkar, T
    BIOLOGICAL CHEMISTRY, 2005, 386 (11) : 1165 - 1171
  • [29] Deciphering lipid codes: K-Ras as a paradigm
    Zhou, Yong
    Hancock, John F.
    TRAFFIC, 2018, 19 (03) : 157 - 165
  • [30] B-Raf kinase inhibitors: Hit enrichment through scaffold hopping
    Gopalsamy, Ariamala
    Shi, Mengxiao
    Hu, Yongbo
    Lee, Frederick
    Feldberg, Larry
    Frommer, Eileen
    Kim, Steven
    Collins, Karen
    Wojciechowicz, Donald
    Mallon, Robert
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2431 - 2434
12345